|
Page 1 of 3
BioRealty is a real estate investment, development, and capital advisory firm focused exclusively on the biomedical and biofuels industries.
I. Biomedical (investment/development):
As an investor/developer, BioRealty performs 4 types of transactional services:
- Build-to-Suit Development (leased or owned) – Ground up development of a new facility to-suit.
- Buy-to-Suits (leased or owned) – Acquisition and rehabilitation of an existing facility to satisfy specific client requirements (“to-suit”).
- Life Science Business Park Development – Serves as the development partner to public and private entities seeking to form or expand a life science business park.
- Sale-Leasebacks – Acquisition of an existing facility, which is leased-back to the current occupant.
- Acquisitions - Acquisition of existing biomedical real estate ranging from 0% to 100% leased.
Transaction Parameters: (except for Business Park Development)
BRI develops and/or invests in biomedical facilities with the following characteristics:
| Location: |
Anywhere in the United States or Canada |
| Size: |
Acquisition or development cost in excess of $5M |
Additional criteria for our sale-leasebacks, buy-to-suits and build-to-suits:
| Property Type: |
Biomedical real estate 75% or more leased. Highly specialized facilities will be considered, including biomanufacturing space and fill/finish suites. |
| Tenant Credit: |
Tenant’s which range from venture funded companies in Phase II clinical trials to AAA rated firms |
|
